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Abstract 
Objectives:  To review the available literature on 
prosthetic joint infections and provide recommendations 
on management particularly the importance of identifying 
the causative organism and starting the most appropriate 
antimicrobial therapy. 
Methods:  The medical literature was searched using 
PubMed, employing the key words prosthetic joint 
infections.  There appears to be no UK consensus 
guidelines on the management of prosthetic joint 
infections or the use of prophylactic antibiotics to prevent 
them.  There is however a number of key documents and 
trust policies which deal with the subject extensively.  We 
also made use of ‘The Sanford Guide to Antimicrobial 
therapy 2012’ for the latest recommendations on the 
correct antimicrobial therapy. 
Conclusion: Although diagnosis is often difficult, there 
are a number of investigations which can help us identify 
the organism.  We recommend that the local prevalence of 
such infections is studied together with identification of 
the commonest organisms.  Work is already underway 
between the infectious disease team and orthopaedic 
surgeons to devise locally adapted protocols for the 
identification and management of such infections. They 
should work in close liaison to implement the correct 
treatment which often involves a combination of both 
surgical and antimicrobial therapy. 
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Introduction 
Infections of prosthetic joints represent a 
devastating complication with a high morbidity and 
mortality and also substantial costs.  Diagnosis 
depends on a number of clinical signs and symptoms, 
blood tests, histopathology, imaging and 
microbiological tests. It is often difficult to distinguish 
from aseptic failure of the joint.  Treatment involves 
adequate antimicrobial therapy and often surgery is 
necessary. 
The purpose of this review is to discuss the 
diagnosis, management and prevention of prosthetic 
joint infections according to current available literature 
and to stress the need for guidelines both for 
management of these infections and their prevention. 
Currently there appears to be no UK consensus 
guidelines on the management of prosthetic joint 
infections.  There is however a number of key 
documents and trust policies which deal with the 
subject extensively and which can be combined into 
one main consensus guideline. 
 
 
Methods 
Two reviewers (CF and PF) independently 
performed a systematic review of the literature. The 
following terms were used in searches of the PubMed 
database: ‘prosthetic joints’, ‘prosthetic joint 
infections’, ‘joint infections’ and ‘orthopaedic 
infections’.  Publications available between the years 
2000 and 2010 were considered so as to focus on the 
latest data available. From a total of about 2000 
articles, approximately 250 relevant papers written in 
the English language were reviewed. Citations of key 
articles were also identified and reviewed. The final 
selected articles are cited in this document and listed 
as references. Additional information was obtained 
from the ‘The Sanford Guide to Antimicrobial therapy 
2012’ for the latest recommendations on the correct 
antimicrobial therapy. 
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Pathogenesis 
Prosthesis associated infections are caused by micro-
organisms in biofilms.  These are micro-organisms that 
grow in clusters attached to the surface, in a hydrophilic 
extracellular matrix.
1
  Micro-organisms in this biofilm are 
more resistant than normal counterparts due to lack of 
metabolic substances and accumulation of waste products 
which allow them to enter a slow, non-growing state.  
They are in an ideal environment to resist host immunity 
and antibiotics.  Staphylococcus epidermidis and 
Staphylococcus aureus usually adhere to the surface of the 
foreign body and rapidly accumulate to form the biofilm.  
The presence of a foreign body decreases the minimal 
infecting dose of such organisms. 
 
Epidemiology 
It is difficult to estimate the incidence rate of prosthetic 
infections, because of probable underestimation since 
some cases may be presumed to be aseptic failure.  This is 
also true because the prosthetic joint remains always at 
risk to haematogenous seeding during the whole lifetime.  
In the first two years, the infection rate is thought to be 
<1% in hip and shoulder prosthesis, <2% in knee 
prosthesis and <9% in elbow prosthesis.
2
 
This obviously depends on the centre and also if it is a 
revision operation where the operation risk increases up to 
40%.
1
 
The incidence of prosthetic joint infections has 
decreased due to better pre-operative prophylaxis and 
laminar flow in operating theatres, but it is thought that it 
will be increasing in the future due to better detection 
methods, the ageing population, increased use of prosthetic 
joints and the increased resistance time of these joints. 
 
Causative organisms 
Commonly identified organisms are shown in Table 1.
1 
Polymicrobial infections, with MRSA and anaerobes being 
the most common organisms, occur more likely in patients 
with soft tissue defects, dehiscence and old age.
3
  
Polymicrobial infections tend to be found in early 
infections.
4 
The local prevalence of prosthetic joint 
infections and the organisms commonly involved is not 
currently available because microbiology data is all 
grouped under ‘wound swabs’ or tissue biopies, which 
obviously include other orthopaedic wound infections.  
The impression of the authors is however that our rates of 
S. aureus and especially of MRSA are much higher. 
 
Clinical presentation and classification 
Leading signs of joint infections include erythema, pain, 
limitation of movement, fever, oedema, haematomas and 
poor wound healing.  Low grade infections can present 
with only some loosening of the joint with or without pain, 
making it difficult to distinguish from aseptic failure.  Late 
infections usually present with systemic symptoms 
following unrecognised bacteraemia from teeth, skin, 
lung or urinary tract. 
Prosthetic infections can be classified into early, 
delayed (or low grade infections) and late infections as 
shown in Table 2.
5,6
 
 
 
Micro-organisms Frequency 
Coagulase negative 
Staphylococcus 
30-43% 
Staphylococcus aureus 12-23% 
Streptococci 9-10% 
Enterococci 3-7% 
Gram negative bacilli 3-6% 
Anaerobes 2-4% 
Polymicrobial 10-12% 
Unknown 10-11% 
Table 1  Commonly identified micro-organisms
1 
 
 
Risk factors 
Spread of infection is thought to occur in one of 
three ways. 
1. Perioperative inoculation of micro-organisms 
in the wound. 
2. Haematogenous spread from a distant source 
of infection. 
3. Contiguous from a focus source e.g. infection 
due to penetrating trauma or previous 
osteomyelitis. 
Rheumatoid arthritis, psoriasis, 
immunosuppression, steroids, poor nutrition, diabetes 
and old age are thought to be risk factors.
1 
Some also 
claim malignancy, superficial infection at surgery and 
poor arthroplasty technique.
7 
The overall risk of 
bacteraemia appeared low in one study at 0.3%
8
 but 
increased to 34% if the organism is S. aureus. 
Haematogenous spread appears to affect knee more 
than hip prosthesis.
1
   
According to S. Esposito in a recent clinical review, 
the most important risk factors are co-morbidities and 
prior joint replacements.
9 
A study done in 2007 in 
Melbourne, Australia, assessed the risk factors for 
acute prosthetic joint infections and found that there 
was a correlation between having a Body Mass Index 
of >=30 with two or more co-morbidities and an 
increased risk of prosthetic joint infections.  Diabetes 
was also a potential risk factor.  Other factors were 
assessed but were not found to significantly contribute 
to the risk of infections.  These were smoking, 
increasing age, prior haemoglobin levels and length of 
hospital stay.
10 
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Early (<3months) 
29-45% 
Acquired during surgery or up to 4 
days later. 
Organisms involved are highly 
virulent e.g. S. aureus or gram 
negative bacilli. 
Delayed (3-24 
months) 
23-41% 
Acquired during surgery   
Organisms less virulent e.g. coagulase 
negative Staphylococci. 
Late (>24 months) 
30-33% 
Due to haematogenous seeding from 
remote infections 
Table 2 Classification of prosthetic joint infections
5,6 
 
 
Investigations 
There is no single test which is sensitive and specific 
enough to diagnose prosthetic joint infections; therefore a 
group of carefully chosen tests should accompany the 
clinical examination. These tests include:  blood tests, 
microbiology, histological and radiological investigations: 
 
1. Full blood count and inflammatory markers – can 
be suggestive of an infection but are definitely not at 
all specific.  C reactive protein rises post-op and 
gradually decreases within weeks.  A series of 
measurements of CRP is therefore more informative 
than a single value. 
2. Synovial fluid aspirate for leukocyte count and 
differential – helps differentiate an infection from 
aseptic failure.  A synovial fluid count >1.7X10
9
/l and 
>65% neutrophils had a sensitivity for diagnosing 
prosthetic joint infections of 94% and 97% and a 
specificity of 88% and 98% respectively.
11
 
3. Histology of the periprosthetic tissue has 80% 
sensitivity and 90% specificity but it is difficult to 
interpret and inflammatory changes vary between 
specimens and even in the same patient.  Fink et al in 
2008
12
 compared the value of synovial biopsy, joint 
aspiration and CRP in diagnosing late prosthetic joint 
infection of total knee replacements.  They found that 
biopsy had a sensitivity of 100% and a specificity of 
98%.  Aspirate had a sensitivity of 72.5% and 
specificity of 95.2% whilst CRP had a sensitivity of 
72%%, and a specificity of 80.9%. 
4. Microbial specimens –  
a) Culture from a sinus tract or wound often results in 
contaminants from the skin giving misleading 
results.  Only if Staphylococcus aureus is cultured is 
this highly predictive of the causative organism.
13
 
b) Synovial fluid aspiration detects the infective 
organism in 45-100% of cases. 
14
 
c) Synovial fluid PCR analysis.  PCR has higher 
sensitivity, specificity and accuracy versus 
culture.  It increases the utility of pre-operative 
aspiration for patients who require revision total 
joint surgery. 
15
 
d) Perioperative specimens provide the most 
accurate specimens for detection of 
microorganisms with a sensitivity of 65-94%
16-18
 
Taking swabs should be avoided and antibiotics 
should be stopped for two weeks prior to 
surgery. 
e) If the prosthesis is removed, this too can be 
cultured. 
Dempsey et al in a study in 2007
19
 explained 
that it is difficult to isolate the bacteria present 
on the surface of the joint by traditional methods 
because the bacteria are strongly adherent to the 
biofilm and because of antibiotic containing 
cement.  They used mild ultrasonification to 
remove adherent microbes from the joint and 
then used molecular techniques to detect the 
microbial DNA from bacteria.  Using PCR they 
managed to detect bacteria in 72% of prosthetic 
hip joints removed whilst there was only a 22% 
detection rate by conventional cultures 
5. Imaging 
a) Plain X-rays – Although neither sensitive nor 
specific, a continuous radiolucent line >2mm or 
severe osteolysis within the first 12 months is 
suggestive of infection.  Fig 1 
b) Ultrasound – may detect effusions and help 
guide aspirations 
c) Contrast arthrography increases the accuracy 
of assessment.  Synovial pouches or abscesses 
are suggestive of infections. 
d) Bone scintigraphy with 
99m
Tc has good 
sensitivity but low specificity.  This is also 
because bone remodelling is normally present 
for the first year post op. If monoclonal 
antibodies are added to 
99m
Tc accuracy is 
increased to 81%. 
e) CT/MRI – Definitely more sensitive than plain 
x-rays but metal implants tend to create 
numerous artefacts. 
 
 
Treatment 
The aim of successful treatment of prosthetic joint 
infections is to obtain a long-term pain-free and 
functional joint.  There are 4 surgical options which 
together with the correct antimicrobial therapy try to 
achieve this. 
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Surgery 
1. Debridment with retention of prosthesis.   This 
is only advisable if symptoms are <3 weeks old, 
the joint is stable, there are no sinus tracts and the 
organisms are highly susceptible to antimicrobials.  
Under these conditions it is claimed to have a 
success rate of >70%.
2,20
 
Zimmerli et al carried out a randomized control 
study in 1998 
20
 whereby patients underwent 
debridment without removal of the joint and were 
given ciprofloxacin and rifampicin.  Cure rate for 
Staphylococcal infections was 100%. 
2. One-stage approach – This involves the removal 
and insertion of a new prosthesis during the same 
operation together with antimicrobials.  It is 
suggested if the soft tissue is intact or very 
minimally compromised and the organisms are not 
very virulent.  In such cases an 86%-100% cure 
rate is claimed.
21-23
 
3. Two-stage approach – This is the removal of the 
prostheses with insertion of a new prosthesis at a 
later date.  It the organisms are not so virulent, a 
spacer (temporary, antibiotic-impregnated bone 
cement) is inserted and the joint replaced after 2-4 
weeks. 
This method has the highest cure rate usually 
>90%
2,24-29
 however it comes at a higher cost and a 
fastidious wait for the patient. 
4. Permanent removal of the prosthetic joint is 
only indicated when the risk of reinfection is very 
high e.g. in immunosuppressed patients.  Very 
debilitated, inoperable patients can be kept on long 
term antimicrobials.  This obviously controls the 
infection but no cure occurs.  80% relapse occurs 
if antibiotics are stopped. 
 
 
Antimicrobial therapy 
Table 3 summarises the choice of antimicrobials for the 
most common organisms as suggested in ‘The Sanford 
Guide to Antimicrobial Therapy 2012’.30  The 
recommended treatment duration is 3 months for hip 
prosthesis and 6 months for knee prosthesis.
2 
 Intravenous 
treatment can be given for the first 2-4 weeks then 
switched to oral therapy.  If a two stage surgical approach 
is chosen, antibiotics are stopped 2 weeks before 
reimplantation to obtain reliable tissue cultures and 
document treatment success.  After reinsertion of the joint, 
antimicrobials are restarted.  If cultures of the 
intraoperative specimens remain negative treatment is 
stopped; if still positive treatment is continued for 3 to 6 
months as above. 
 
 
 
Organism Antibiotic 
S. pyogenes, 
Grp A,B or G, 
viridans strep 
Penicillin G or Ceftriaxone 2 g dly x 4wks 
MSSE/MSSA Nafcillin or oxacillin 2g 4hrly iv + 
rifampicin 300mg iv bd x 6wks 
or 
Vancomycin 1g iv 12hlry + Rifampicin 
300mg po bd x 6wks 
or 
Daptomycin 6mg/kg iv 24hrly + 
Rifampicin 300mg po bd x 6wks. 
MRSE/MRSA Vancomycin 1g iv 12hrly + Rifampicin 
300mg po bd x 6wks 
or  
Ciprofloxacin 750mg iv/po bd (or 
Levofloxacin 750mg iv/po dly) + 
rifampicin or Linezolid or Daptomycin and 
Rifampicin x 6wks 
P. 
aeuroginosa 
Ceftriaxone 2g dly iv + Ciprofloxacin 
750mg iv/po bd (or Levofloxacin 750mg 
iv/po dly) 
Table 3  Choice of antibiotic regime
30 
MSSE=methicillin sensitive Staphylococcus epidermis 
MSSA= methicillin sensitive Staphylococcus aureus 
MRSE= methicillin resistant Staphylococcus epidermis 
MRSA=methicillin resistant Staphylococcus aureus. 
 
Treatment outcome is monitored both clinically and 
by taking serial blood tests mainly inflammatory 
markers and full blood count.  The patient should be 
reviewed regularly with these results for at least a year 
after the infection 
 
Prevention of prosthetic joint infections 
The importance of prevention of late 
haematogenous infection is well understood but often 
overlooked.  Haematogenous infection of a prosthetic 
joint replacement is a devastating complication that 
can lead to the loss of that joint and significant 
morbidity.
 
There seems to be some controversy in the 
literature whether antibiotic prophylaxis should be 
administered or not.  The overall risk of 
haematogenous infection from any source is variously 
reported as 0.4-1.7%
8,31
 
In comprehensive reviews of literature, Thyne and 
Ferguson in 1991
32
, the American Dental 
Association/American Academy of Orthopaedic 
Surgeons in 1997
33
 and Tong and Rothwell in 2000
34
 
have concluded that there is minimal evidence of 
haematological infection of prosthetic joints by oral 
organisms at 0.00-0.01%.  They suggest that the risk 
of antibiotic prophylaxis outweighs the benefits. 
Notwithstanding this data, the 1997 combined 
advisory statement of the American Dental 
Association recommends that patients at a potentially 
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increased risk of haematological spread of infection to a 
prosthetic joint should have antibiotic prophylaxis before 
dental procedures likely to cause bacteraemia. 
The antibiotics chosen must be active against viridans 
streptococcal infections as they are the most significant 
oral organisms. 
The Sanford 2012 guidelines
35
 recommend using the 
same prophylaxis as in cardiac patients at risk of 
endocarditis.  It quotes the Journal of the American Dental 
Association
36
 in saying that most patients with prosthetic 
joints do not require prophylaxis for routine dental 
procedures but individual considerations prevail in high 
risk procedures. 
 
Conclusion 
 Prosthetic joint infections are caused by micro-
organisms in biofilms.  This makes them more 
resistant and difficult to eradicate. 
 Coagulase negative staphylococci and 
Staphylococcus aureus are the most common 
organisms. 
 Infections are classified into early (<3months), 
delayed (3-24months) and late (<24months). 
 Clinical signs such as erythema, fever, pain and 
loosening of the joint are common but it is often 
difficult to distinguish infection from aseptic 
failure. 
 Other co-morbidities present risk factors to getting 
prosthetic joint infections. 
 There is no single investigation but a collection of 
blood tests, histopathological, microbiological and 
radiological investigations.  
 The ideal treatment is surgery and antimicrobial 
agents tailored on the above results.  
 The aim of treatment is to obtain a long-term, 
pain-free and functional joint. 
 
The optimum management of implant associated 
infection is still a subject of debate.  More randomized 
clinical studies which take into account the various aspects 
of treatment, the selection and duration of antibiotic 
therapy and the time and scope of surgery are necessary.  
Also we believe that there need to be guidelines on the use 
of prophylactic antibiotics in patients with prosthetic joints.  
Better molecular techniques will help increase the yield in 
identifying the organism and therefore target the 
antimicrobial therapy better.  
We recommend that the local prevalence of such 
infections is studied together with identification of the 
commonest organisms.  This can be done by labelling 
wound swabs and deep biopsies from such patients as 
possible ‘prosthetic joint infections’ so they can be 
classified separately from other wound infections.  Work is 
already underway between the infectious disease team and 
orthopaedic surgeons to devise locally adapted 
protocols. Better liaison between the infectious 
diseases team, the micobiologists and orthopaedic 
surgeons is of paramount importance so that such 
infections are identified early and the correct 
management steps are taken. 
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